---
title: "Charles River Laboratories International Inc. Stock Underperforms Wednesday When Compared To Competitors"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/294263954.md"
description: "Charles River Laboratories (CRL) stock underperformed competitors on Wednesday, sliding 2.34% to $234.80 amid a broader market decline. The S&P 500 and Dow Jones fell 1.52% and 2.19%, respectively. CRL closed 3.27% below its 52-week high of $242.73. Trading volume reached 1.1 million shares, exceeding the 50-day average."
datetime: "2026-07-29T21:16:43.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/294263954.md)
  - [en](https://longbridge.com/en/news/294263954.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/294263954.md)
generator: "portal-rs"
---

# Charles River Laboratories International Inc. Stock Underperforms Wednesday When Compared To Competitors

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Charles River Laboratories International Inc. (CRL) slid 2.34% to $234.80 Wednesday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index falling 1.52% to 7,316.15 and Dow Jones Industrial Average falling 2.19% to 51,594.14.

Charles River Laboratories International Inc. closed 3.27% short of its 52-week high of $242.73, which the company achieved on July 28th.

The stock underperformed when compared to some of its competitors Wednesday, as Labcorp Holdings Inc. (LH) fell 2.25% to $307.15, Alnylam Pharmaceuticals Inc. (ALNY) fell 0.62% to $286.62, and Bio-Techne Corp. (TECH) fell 0.06% to $72.03.

Trading volume (1.1 M) eclipsed its 50-day average volume of 897,788.

Data source: Dow Jones Market Data, FactSet. Data compiled July 29, 2026.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

(END) Dow Jones Newswires

07-29-26 1716ET

### Related Stocks

- [CRL.US](https://longbridge.com/en/quote/CRL.US.md)
- [LH.US](https://longbridge.com/en/quote/LH.US.md)
- [ALNY.US](https://longbridge.com/en/quote/ALNY.US.md)
- [TECH.US](https://longbridge.com/en/quote/TECH.US.md)
- [.SPX.US](https://longbridge.com/en/quote/.SPX.US.md)
- [.DJI.US](https://longbridge.com/en/quote/.DJI.US.md)

## Related News & Research

- [Insider Move at Charles River Labs: Director Cashes In on Company Stock](https://longbridge.com/en/news/296571643.md)
- [Charles River Labs director Nancy C. Andrews disposes of 573 common shares worth $163,442.52](https://longbridge.com/en/news/296533503.md)
- [If You Invested $100 In Charles River Stock 15 Years Ago, You Would Have This Much Today](https://longbridge.com/en/news/295982117.md)
- [Charles River and MVC to develop enterovirus vaccine](https://longbridge.com/en/news/296594849.md)
- [Charles River partners with Medigen Vaccine Biologics on NGS-backed multivalent enterovirus vaccine development](https://longbridge.com/en/news/296486690.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**